At Reuters Pharma USA, a who’s who of executives from major pharma companies will gather in Philadelphia to go in-depth on every part of the business, from marketing and market access to re
The pharma industry has been facing increasing pressure in recent years to adopt eco-friendly practices without compromising product safety or efficacy.
Dr Leeza Osipenko and colleagues analysed the quality of clinical evidence submitted by companies to NICE technology appraisals (TAs) over the last 20 years.
The way HTAs are conducted in Europe is changing. And, if organisations act now to overcome the challenges, they could reap the rewards for years to come.